Cencora COR saw a lowered price target from Wells Fargo, however, it managed to raise $1.8B in Senior Notes Offering to fund key healthcare acquisitions. Despite uneven fiscal third-quarter results, a $100 invested in Cencora 5 years ago would show significant return today. Multiple entities, including Tidal Investments, XTX Topco Ltd, World Investment Advisors, and Virtu Financial, have increased their holdings in the company.
Cencora continues to reflect favorable value, momentum and growth stocks. Also, the company's acquisition of Retina Consultants for $4.6B promises EPS growth. Despite the reported soft earnings and a 2.8% drop since the last earnings report, Cencora's stock strengthened, hitting a fresh high. The company also announced the date for its fourth quarter fiscal 2024 earnings release and expanded its enterprise leadership team with two senior appointments. Significant market activities around the company's stock include purchases by several firms and insider selling. Cencora's Q3 earnings beat estimates and the company reported strong revenue and EPS growth in 2024.
Walgreens Boots Alliance sold significant shares of Cencora for both $1.1bn and $400m separately. Lastly, Cencora announced a common share repurchase from Walgreens Boots Alliance and strategic acquisition of Retina Consultants of America.
Cencora COR News Analytics from Wed, 22 May 2024 07:00:00 GMT to Sat, 14 Dec 2024 18:02:30 GMT -
Rating 2
- Innovation 5
- Information 8
- Rumor 7
